Search research articles
Contact Us
Filters
Showing results (1-10 of 325) with videos related to
Page
of 33
Sort By:
Molecular and Cellular Neurosciences
|
July 1, 2026
Reflections from Mathias Bähr, PhD, Editor-in-Chief for Molecular and Cellular Neuroscience, 2017-2026
Mathias Bähr
Experimental Neurology
|
July 6, 2010
Special issue on multiple sclerosis
Mathias Bähr
Molecular and Cellular Neurosciences
|
May 28, 2019
Disease signatures: Biomarkers/indicators of neurodegeneration
Henrik Zetterberg, Mathias Bähr
Stroke
|
September 23, 2003
Editorial comment--Remote evaluation of acute ischemic stroke: a reliable tool to extend tissue plasminogen activator use to community and rural stroke patients?
Olaf Crome, Mathias Bähr
Molecular Biosystems
|
October 18, 2007
Targeting neurological disease with RNAi
Paul Lingor, Mathias Bähr
Advances in Experimental Medicine and Biology
|
September 8, 2006
Brain repair: Experimental treatment strategies, neuroprotective and repair strategies in the lesioned adult CNS
Mathias Bähr, Paul Lingor
Journal of Neurochemistry
|
September 22, 2016
Is there a role of Tau in Huntington's disease?
Inga Zerr, Mathias Bähr
Journal of Neurobiology
|
March 10, 2004
Growth and guidance cues for regenerating axons: where have they gone?
Paulo D Koeberle, Mathias Bähr
Experimental Neurology
|
September 1, 2009
Future neuroprotective strategies
Muriel B Sättler, Mathias Bähr
Biochimica Et Biophysica Acta
|
May 12, 2015
Dimerization propensities of Synucleins are not predictive for Synuclein aggregation
Katrin Eckermann, Sebastian Kügler, Mathias Bähr
Page
of 33
Search research articles
Search
Showing results (1-10 of 325) with videos related to
Sort By:
Page
of 33
Molecular and Cellular Neurosciences
|
July 1, 2026
Reflections from Mathias Bähr, PhD, Editor-in-Chief for Molecular and Cellular Neuroscience, 2017-2026
Mathias Bähr
Experimental Neurology
|
July 6, 2010
Special issue on multiple sclerosis
Mathias Bähr
Molecular and Cellular Neurosciences
|
May 28, 2019
Disease signatures: Biomarkers/indicators of neurodegeneration
Henrik Zetterberg, Mathias Bähr
Stroke
|
September 23, 2003
Editorial comment--Remote evaluation of acute ischemic stroke: a reliable tool to extend tissue plasminogen activator use to community and rural stroke patients?
Olaf Crome, Mathias Bähr
Molecular Biosystems
|
October 18, 2007
Targeting neurological disease with RNAi
Paul Lingor, Mathias Bähr
Advances in Experimental Medicine and Biology
|
September 8, 2006
Brain repair: Experimental treatment strategies, neuroprotective and repair strategies in the lesioned adult CNS
Mathias Bähr, Paul Lingor
Journal of Neurochemistry
|
September 22, 2016
Is there a role of Tau in Huntington's disease?
Inga Zerr, Mathias Bähr
Journal of Neurobiology
|
March 10, 2004
Growth and guidance cues for regenerating axons: where have they gone?
Paulo D Koeberle, Mathias Bähr
Experimental Neurology
|
September 1, 2009
Future neuroprotective strategies
Muriel B Sättler, Mathias Bähr
Biochimica Et Biophysica Acta
|
May 12, 2015
Dimerization propensities of Synucleins are not predictive for Synuclein aggregation
Katrin Eckermann, Sebastian Kügler, Mathias Bähr
Page
of 33